MediWound Showcases New Wound Healing Data Across 3 Global Conferences, EscharEx Study Results Back Late-Stage Trials And Expansion Into Diabetic Ulcers
MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced multiple oral and poster presentations at three leading wound care conferences: the Wound Healing
04/07/2026